FR2329668A1 - Procede de preparation d'aminotriazolobenzodiazepines - Google Patents
Procede de preparation d'aminotriazolobenzodiazepinesInfo
- Publication number
- FR2329668A1 FR2329668A1 FR7532815A FR7532815A FR2329668A1 FR 2329668 A1 FR2329668 A1 FR 2329668A1 FR 7532815 A FR7532815 A FR 7532815A FR 7532815 A FR7532815 A FR 7532815A FR 2329668 A1 FR2329668 A1 FR 2329668A1
- Authority
- FR
- France
- Prior art keywords
- benzodiazepines
- triazolo
- viii
- alkyl
- hydrazino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- -1 tranquillising Substances 0.000 title abstract 3
- 239000000935 antidepressant agent Substances 0.000 title abstract 2
- 229940005513 antidepressants Drugs 0.000 title abstract 2
- 229940049706 benzodiazepine Drugs 0.000 title abstract 2
- 239000000932 sedative agent Substances 0.000 title abstract 2
- MPBFJUHXJSCIBR-UHFFFAOYSA-N 1h-1,2-benzodiazepin-3-ylhydrazine Chemical class C1=CC(NN)=NNC2=CC=CC=C21 MPBFJUHXJSCIBR-UHFFFAOYSA-N 0.000 title 1
- 230000001430 anti-depressive effect Effects 0.000 title 1
- 230000001624 sedative effect Effects 0.000 title 1
- GUJAGMICFDYKNR-UHFFFAOYSA-N 1,4-benzodiazepine Chemical class N1C=CN=CC2=CC=CC=C12 GUJAGMICFDYKNR-UHFFFAOYSA-N 0.000 abstract 4
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- AUIVPHFCEWETCK-UHFFFAOYSA-N 2-(1H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-1-yl)ethanamine Chemical class C1(N=NC=2N1C1=C(C=NC=2)C=CC=C1)CCN AUIVPHFCEWETCK-UHFFFAOYSA-N 0.000 abstract 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 2
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 2
- BOMGSODHUPVXJU-UHFFFAOYSA-N 1h-1,4-benzodiazepin-2-ylhydrazine Chemical class N1C(NN)=CN=CC2=CC=CC=C21 BOMGSODHUPVXJU-UHFFFAOYSA-N 0.000 abstract 1
- QWEJEQQJNBKACP-UHFFFAOYSA-N 2-(8-chloro-6-phenyl-4h-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-1-yl)-n,n-dimethylethanamine Chemical compound C12=CC(Cl)=CC=C2N2C(CCN(C)C)=NN=C2CN=C1C1=CC=CC=C1 QWEJEQQJNBKACP-UHFFFAOYSA-N 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000004414 alkyl thio group Chemical group 0.000 abstract 1
- 150000001557 benzodiazepines Chemical class 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000012024 dehydrating agents Substances 0.000 abstract 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 229940035363 muscle relaxants Drugs 0.000 abstract 1
- 239000003158 myorelaxant agent Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229940125723 sedative agent Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7532815A FR2329668A1 (fr) | 1975-10-27 | 1975-10-27 | Procede de preparation d'aminotriazolobenzodiazepines |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7532815A FR2329668A1 (fr) | 1975-10-27 | 1975-10-27 | Procede de preparation d'aminotriazolobenzodiazepines |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2329668A1 true FR2329668A1 (fr) | 1977-05-27 |
| FR2329668B1 FR2329668B1 (fr) | 1979-07-27 |
Family
ID=9161688
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR7532815A Granted FR2329668A1 (fr) | 1975-10-27 | 1975-10-27 | Procede de preparation d'aminotriazolobenzodiazepines |
Country Status (1)
| Country | Link |
|---|---|
| FR (1) | FR2329668A1 (fr) |
Cited By (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8981083B2 (en) | 2010-05-14 | 2015-03-17 | Dana Farber Cancer Institute, Inc. | Compositions and methods for treating neoplasia, inflammatory disease and other disorders |
| US9789120B2 (en) | 2010-05-14 | 2017-10-17 | Dana-Farber Cancer Institute, Inc. | Male contraceptive compositions and methods of use |
| AU2015201727B2 (en) * | 2010-05-14 | 2018-03-08 | Dana-Farber Cancer Institute, Inc. | Compositions and methods for treating neoplasia, inflammatory disease and other disorders |
| US9951074B2 (en) | 2014-08-08 | 2018-04-24 | Dana-Farber Cancer Institute, Inc. | Dihydropteridinone derivatives and uses thereof |
| US9975896B2 (en) | 2013-07-25 | 2018-05-22 | Dana-Farber Cancer Institute, Inc. | Inhibitors of transcription factors and uses thereof |
| US10124009B2 (en) | 2014-10-27 | 2018-11-13 | Tensha Therapeutics, Inc. | Bromodomain inhibitors |
| US10150756B2 (en) | 2014-01-31 | 2018-12-11 | Dana-Farber Cancer Institute, Inc. | Diaminopyrimidine benzenesulfone derivatives and uses thereof |
| US10308653B2 (en) | 2014-08-08 | 2019-06-04 | Dana-Farber Cancer Institute, Inc. | Diazepane derivatives and uses thereof |
| US10676484B2 (en) | 2010-05-14 | 2020-06-09 | Dana-Farber Cancer Institute, Inc. | Compositions and methods for treating leukemia |
| US10702527B2 (en) | 2015-06-12 | 2020-07-07 | Dana-Farber Cancer Institute, Inc. | Combination therapy of transcription inhibitors and kinase inhibitors |
| US10793571B2 (en) | 2014-01-31 | 2020-10-06 | Dana-Farber Cancer Institute, Inc. | Uses of diazepane derivatives |
| US10881668B2 (en) | 2015-09-11 | 2021-01-05 | Dana-Farber Cancer Institute, Inc. | Acetamide thienotriazolodiazepines and uses thereof |
| US10913752B2 (en) | 2015-11-25 | 2021-02-09 | Dana-Farber Cancer Institute, Inc. | Bivalent bromodomain inhibitors and uses thereof |
| US10925881B2 (en) | 2014-02-28 | 2021-02-23 | Tensha Therapeutics, Inc. | Treatment of conditions associated with hyperinsulinaemia |
| US11306105B2 (en) | 2015-09-11 | 2022-04-19 | Dana-Farber Cancer Institute, Inc. | Cyano thienotriazolodiazepines and uses thereof |
| US11446309B2 (en) | 2013-11-08 | 2022-09-20 | Dana-Farber Cancer Institute, Inc. | Combination therapy for cancer using bromodomain and extra-terminal (BET) protein inhibitors |
-
1975
- 1975-10-27 FR FR7532815A patent/FR2329668A1/fr active Granted
Cited By (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10407441B2 (en) | 2010-05-14 | 2019-09-10 | Dana-Farber Cancer Institute, Inc. | Compositions and methods for treating neoplasia, inflammatory disease and other disorders |
| AU2011252808B2 (en) * | 2010-05-14 | 2015-05-14 | Dana-Farber Cancer Institute, Inc. | Compositions and methods for treating neoplasia, inflammatory disease and other disorders |
| US9789120B2 (en) | 2010-05-14 | 2017-10-17 | Dana-Farber Cancer Institute, Inc. | Male contraceptive compositions and methods of use |
| AU2015201727B2 (en) * | 2010-05-14 | 2018-03-08 | Dana-Farber Cancer Institute, Inc. | Compositions and methods for treating neoplasia, inflammatory disease and other disorders |
| US10676484B2 (en) | 2010-05-14 | 2020-06-09 | Dana-Farber Cancer Institute, Inc. | Compositions and methods for treating leukemia |
| US8981083B2 (en) | 2010-05-14 | 2015-03-17 | Dana Farber Cancer Institute, Inc. | Compositions and methods for treating neoplasia, inflammatory disease and other disorders |
| US9975896B2 (en) | 2013-07-25 | 2018-05-22 | Dana-Farber Cancer Institute, Inc. | Inhibitors of transcription factors and uses thereof |
| US11446309B2 (en) | 2013-11-08 | 2022-09-20 | Dana-Farber Cancer Institute, Inc. | Combination therapy for cancer using bromodomain and extra-terminal (BET) protein inhibitors |
| US10730860B2 (en) | 2014-01-31 | 2020-08-04 | Dana-Farber Cancer Institute, Inc. | Diaminopyrimidine benzenesulfone derivatives and uses thereof |
| US10150756B2 (en) | 2014-01-31 | 2018-12-11 | Dana-Farber Cancer Institute, Inc. | Diaminopyrimidine benzenesulfone derivatives and uses thereof |
| US10793571B2 (en) | 2014-01-31 | 2020-10-06 | Dana-Farber Cancer Institute, Inc. | Uses of diazepane derivatives |
| US10925881B2 (en) | 2014-02-28 | 2021-02-23 | Tensha Therapeutics, Inc. | Treatment of conditions associated with hyperinsulinaemia |
| US9951074B2 (en) | 2014-08-08 | 2018-04-24 | Dana-Farber Cancer Institute, Inc. | Dihydropteridinone derivatives and uses thereof |
| US10308653B2 (en) | 2014-08-08 | 2019-06-04 | Dana-Farber Cancer Institute, Inc. | Diazepane derivatives and uses thereof |
| US10124009B2 (en) | 2014-10-27 | 2018-11-13 | Tensha Therapeutics, Inc. | Bromodomain inhibitors |
| US10702527B2 (en) | 2015-06-12 | 2020-07-07 | Dana-Farber Cancer Institute, Inc. | Combination therapy of transcription inhibitors and kinase inhibitors |
| US10881668B2 (en) | 2015-09-11 | 2021-01-05 | Dana-Farber Cancer Institute, Inc. | Acetamide thienotriazolodiazepines and uses thereof |
| US11306105B2 (en) | 2015-09-11 | 2022-04-19 | Dana-Farber Cancer Institute, Inc. | Cyano thienotriazolodiazepines and uses thereof |
| US11406645B2 (en) | 2015-09-11 | 2022-08-09 | Dana-Farber Cancer Institute, Inc. | Acetamide thienotriazolodiazepines and uses thereof |
| US10913752B2 (en) | 2015-11-25 | 2021-02-09 | Dana-Farber Cancer Institute, Inc. | Bivalent bromodomain inhibitors and uses thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| FR2329668B1 (fr) | 1979-07-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR2329668A1 (fr) | Procede de preparation d'aminotriazolobenzodiazepines | |
| KR950032199A (ko) | 이미다조디아제핀 | |
| DE69021472D1 (de) | Pyrazolderivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammenstellung. | |
| DE69230163D1 (de) | Thiazolylbenzofuranderivate, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen, die sie enthalten | |
| KR970015576A (ko) | 신규 히디록시피리디논 | |
| DE2963929D1 (en) | Heterocyclic derivatives of (4-(piperazin-1-yl-phenyloxymethyl)-1.3.-dioxolan-2-ylmethyl)-1h-imidazoles and -1h-1.2.4-triazoles, their preparation and use as fungicides and bactericides | |
| GB1254403A (en) | Benzodiazepine derivatives | |
| CA2184802A1 (fr) | Procede pour l'obtention de derives de l'imidazobenzodiazepine | |
| CS5291A3 (en) | Imidazole derivatives, process of their preparation and use | |
| ES479820A1 (es) | Procedimiento para la preparacion de isoquinoleinas. | |
| ZA827140B (en) | 7-bromo-5-(2-halophenyl)-1h-2,3-dihydro-1,4-benzodiazepine compounds,method for their manufacture and pharmaceutical compositions containing them | |
| GB1023793A (en) | The manufacture of benzodiazepine derivatives | |
| CA2245539A1 (fr) | Derives de 2,3-benzodiazepine condenses et leur utilisation comme inhibiteurs de recepteurs d'ampa | |
| ATE42292T1 (de) | Imidazo(1,2-c)pyrimidine und ihre salze, verfahren zu ihrer herstellung, ihre anwendung als arzneimittel und diese enthaltende zubereitungen. | |
| FR2356643A1 (fr) | 5-0-acyl-imidazole-4-carboxamides, leur obtention et composition pharmaceutique en contenant | |
| YU140491A (sh) | 6-supstituisani-tetrahidrobenz(c,d) indoli | |
| KR920004390A (ko) | 피롤로벤조이미다졸, 이미다조벤족사지논 및 이미다조퀴놀론, 이들의 제조방법, 이들의 용도 및 이 화합물들을 함유하는 제제 | |
| IE800049L (en) | Hexahydro-1, 4-oxazepines | |
| DE69512419D1 (de) | IMIDAZO[1,2-a]INDENO[1,2-e]PYRAZIN-2-CARBONSÄURE DERIVATE, IHRE HERSTELLUNG UND SIE ENTHALTENDE ARZNEIMITTEL | |
| ZA81269B (en) | 2,3-dihydro-imidazo(1,2-b)pyridazine derivatives,their preparation and their use | |
| MY103572A (en) | 3,4-dihydro-2-alkyl-3-oxo-n-aryl-2h-[1] benzothieno [3,2-e]-1,2-thiazine-4-carboxamide-1, 1-dioxides. | |
| IE32791B1 (en) | Benzodiazepine derivatives | |
| FR2253525A1 (en) | 2-(3-Aminopropyl)-triazolo (4,3-a) (1,4) benzodiazepines - used as sedatives, hypnotics anticonvulsants etc | |
| IL85641A0 (en) | Tendamistat derivatives | |
| ES8302665A1 (es) | "procedimiento de preparacion de nuevos derivados de la hidrazina, utiles como fungicidas y bactericidas". |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ST | Notification of lapse |